170 likes | 690 Views
Lecture 7 Hypersensitivity Reactions. Immune responses that result in tissue injury. Immune-mediated hypersensitivity reactions. Type I - Anaphylactic/Atopic Type II - Cytotoxic Type III - Toxic Complex Type IV - T-cell mediated Type V- Stimulatory. Immune-Mediated Hypersensitivities.
E N D
Lecture 7Hypersensitivity Reactions • Immune responses that result in tissue injury
Immune-mediated hypersensitivity reactions • Type I - Anaphylactic/Atopic • Type II - Cytotoxic • Type III - Toxic Complex • Type IV - T-cell mediated • Type V- Stimulatory
Atopy • Describes the clinical features of individuals who develop Type I hypersensitivity • increased vascular permeability • local edema • itching • Strong hereditary linkages • Mediated by a serum factor termed "reagin" • "Wheal and flare" reaction
Immediate and Late-Phase Reactions Wheal-and-flare reaction (lasts up to 30 min post injection) Late-phase reaction (develops approximately eight hours later and persists several hours)
IgE response is a local event • site of allergen entry • local synthesis results in sensitization of local mast cells • spillover of IgE enters circulation and sensitizes mast cells and basophils systemically
Characteristics of IgE • Heat labile • Fc binding destroyed by heating at 56°C for 30 min • antigen binding is not lost • Half-life • serum half-life is 2 1/2 days (IgG is 21 days) • mast cell bound half-life is 12 weeks
IgE Levels in Disease • Normal levels do not preclude atopy • 30% of random population allergic to at least one common allergen • Genetic background puts individual at risk • family history indicates predisposition for atopy • cannot predict specific reactions(s) • higher level of IgE associated with increased risk of atopy
Mast Cell Activation/Degranulation Antigen IgE Fc Receptor
Contents of the Mast Cell Granules Active agent Activity Histamine Increases vascular permeability; elevates level of cyclic AMP Heparin Anticoagulation Serotonin Increases vascular permeability SRS-A Increases vascular permeability; causes contraction of human broncholes Chymase Proteolysis Hyaluronidase Increases vasuclar permeability Eos. Chem. Factor Chemoattraction of eosinophils Neut. Chem. Factor Chemoattraction of neutrophils Platelet Agg. Factor Aggregates platelets
Comparison of IgE and IgG1 Structure • heavy chain domains 5 vs. 4 • mol. wt. 188,000 vs. 146,000 • carbohydrate 12% vs. 2-3% • half-life (serum) 2 1/2 vs. 21d
Risk of allergy: Family 50 40 percent of children with atopy 30 20 10 0 none one both number of parents with history of allergy
Risk of allergy: IgE Levels 100 Percent of subjects 80 60 40 20 0 <60 60-200 200-450 >450 % of population with given IgE concentration % of subjects with that IgE concentration who are atopic
T Cell Control of the IgE Response Thymectomy antigen Ts cells 8 6 specific IgE (arbitrary units) 4 2 control 0 -1 0 1 2 3 4 5 Weeks
Hyposensitization Allergen injections Symptoms IgG Activity Lymph. Trans. IgE Time
Clinical Tests for Allergy • Skin Tests • Immediate Response (wheal & flare reaction; 20 min) • increased vascular permeability • local edema • itching • Late Reactions (5-24 hr) • RAST (Radio Allergo Sorbant Test)